fluorides has been researched along with deferoxamine in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (37.50) | 18.7374 |
| 1990's | 5 (62.50) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lattanzio, FA; Ratz, PH | 1 |
| Casteels, R; De Smedt, H; Missiaen, L; Vrolix, M; Wuytack, F | 1 |
| MacDonald, RA; MacSween, RN; Pechet, GS | 1 |
| Shore, D; Wyatt, RJ | 1 |
| Yokel, RA | 1 |
| Daiho, T; Kanazawa, T; Kubota, T | 1 |
| Barrett, KE; Ries, J; Stein, J; Traynor-Kaplan, AE | 1 |
| Neumann, J; Scholz, H | 1 |
2 review(s) available for fluorides and deferoxamine
| Article | Year |
|---|---|
Aluminum and Alzheimer's disease.
Topics: Aluminum; Alzheimer Disease; Animals; Brain Chemistry; Cell Nucleus; Cooking and Eating Utensils; Deferoxamine; Dementia; Diet; Female; Fluorides; Hair; Humans; Male; Mice; Middle Aged; Neurofibrils | 1983 |
Aluminum chelation: chemistry, clinical, and experimental studies and the search for alternatives to desferrioxamine.
Topics: Adult; Aluminum; Animals; Carboxylic Acids; Chelating Agents; Chelation Therapy; Child; Deferoxamine; Fluorides; Humans; Kidney Failure, Chronic; Nervous System Diseases; Rabbits; Rats; Renal Replacement Therapy | 1994 |
6 other study(ies) available for fluorides and deferoxamine
| Article | Year |
|---|---|
L-type Ca2+ channel desensitization by F- reduces PhE-induced increase in [Ca2+]i but not stress.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium; Calcium Channels; Deferoxamine; Dinoprost; Female; Femoral Artery; Fluorides; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth, Vascular; Phenylephrine; Potassium Chloride; Rabbits; Stress, Mechanical; Time Factors | 1992 |
AlF4- reversibly inhibits 'P'-type cation-transport ATPases, possibly by interacting with the phosphate-binding site of the ATPase.
Topics: Adenosine Triphosphatases; Aluminum; Aluminum Chloride; Aluminum Compounds; Animals; Beryllium; Binding Sites; Ca(2+) Mg(2+)-ATPase; Calcium-Transporting ATPases; Cell Membrane; Chlorides; Deferoxamine; Fluorides; Guanosine 5'-O-(3-Thiotriphosphate); Guanosine Triphosphate; Guanylyl Imidodiphosphate; Isoenzymes; Magnesium; Magnesium Chloride; Nitrophenols; Organophosphorus Compounds; Phosphates; Sodium Fluoride; Sodium-Potassium-Exchanging ATPase; Swine; Thionucleotides | 1988 |
Iron metabolism by reticuloendothelial cells in vitro. Physical and chemical conditions, lipotrope deficiency, and acute inflammation.
Topics: Animals; Ascorbic Acid; Cobalt; Copper; Cysteine; Dactinomycin; Deferoxamine; Dinitrophenols; Edetic Acid; Fatty Liver; Fluorides; Fructose; Glucose; Glutathione; Hemochromatosis; Inflammation; Iodoacetates; Iron; Lipotropic Agents; Liver Cirrhosis; Lung; Macrophages; Microscopy, Electron; Potassium Permanganate; Protein Biosynthesis; Puromycin; Rabbits; RNA; Saponins; Sucrose; Surface-Active Agents; Transferrin; Trypsin | 1969 |
Quasi-irreversible inactivation of the sarcoplasmic reticulum Ca(2+)-ATPase by simultaneous tight binding of magnesium and fluoride to the catalytic site.
Topics: Adenosine Triphosphate; Animals; Binding Sites; Calcium; Calcium-Transporting ATPases; Deferoxamine; Dimethyl Sulfoxide; Enzyme Activation; Fluorides; Kinetics; Magnesium; Phosphorylation; Potassium; Potassium Compounds; Rabbits; Sarcoplasmic Reticulum | 1993 |
Dual role for AlF4(-)-sensitive G proteins in the function of T84 epithelial cells: transport and barrier effects.
Topics: Actins; Aluminum Compounds; Biological Transport; Calcium; Cyclic AMP; Cyclic GMP; Deferoxamine; Epithelium; Fluorides; GTP-Binding Proteins; Humans; Intestinal Mucosa; Permeability; Tumor Cells, Cultured; Type C Phospholipases | 1997 |
Deferoxamine blocks interactions of fluoride and carbachol in isolated mammalian cardiac preparations.
Topics: Adrenergic beta-Agonists; Animals; Carbachol; Deferoxamine; Fluorides; Guinea Pigs; Heart; In Vitro Techniques; Iron Chelating Agents; Isoproterenol; Muscarinic Agonists; Myocardial Contraction; Myocardium; Papillary Muscles; Phosphoprotein Phosphatases; Rats | 1998 |